Table 2 Univariate analyses of clinicopathological factors between patients with death within 1-year and the others in advanced oropharyngeal cancer patients
From: A predictive model for advanced oropharyngeal cancer patients treated with chemoradiation
Variables |  | Early death patients (n = 43) | Other patients (n = 104) | P value |
|---|---|---|---|---|
Age (years) | ≥ 60 | 20(47%) | 62(40%) | 0.146 |
< 60 | 23(53%) | 42(60%) |  | |
Gender | Male | 42(98%) | 97(93%) | 0.284 |
Female | 1(2%) | 7(7%) | Â | |
T | T1 + 2 | 7(16%) | 43(41%) | 0.004* |
T3 + 4 | 36(84%) | 61(59%) |  | |
N | N0 + 1 + 2a | 14(33%) | 51(49%) | 0.067 |
N2b + 2c + 3 | 29(67%) | 53(51%) |  | |
Stage | III | 4(9%) | 15(14%) | 0.400 |
IV | 39(91%) | 89(86%) | Â | |
Disease subsite | Tonsil | 25(58%) | 69(66%) | 0.097 |
Soft palate | 2(5%) | 10(10%) | Â | |
Tongue base | 3(7%) | 11(11%) | Â | |
Pharyngeal wall | 13(30%) | 14(13%) | Â | |
Previous treated cancer | No | 40(93%) | 94(90%) | 0.608 |
Yes | 3(7%) | 10(10%) | Â | |
Syn- or Meta-chronous cancer | No | 36(84%) | 90(87%) | 0.657 |
Yes | 7(16%) | 14(13%) | Â | |
Differentiation | Well | 0(0%) | 3(5%) | 0.370 |
Moderately | 8(18%) | 29(27%) | Â | |
Poorly | 11(26%) | 26(25%) | Â | |
Missing | 24(56%) | 46(43%) | Â | |
HPV (P16) | Positive | 7(16%) | 32(31%) | 0.086 |
Negative | 7(16%) | 22(21%) | Â | |
Missing | 29(68%) | 50(48%) | Â | |
Smoking habit | No | 10(23%) | 23(22%) | 0.943 |
Yes, quitted | 12(28%) | 27(26%) | Â | |
Yes, persistent | 21(49%) | 54(52%) | Â | |
Body Height (cm) | ≥163 | 38(88%) | 72(69%) | 0.015* |
< 163 | 5(12%) | 32(31%) |  | |
Body Weight (kg) | ≥60 | 22(51%) | 73(70%) | 0.014* |
< 60 | 21(49%) | 31(30%) |  | |
BMI (kg/m2) | ≥22 | 18(42%) | 69(66%) | 0.006* |
< 22 | 25(58%) | 35(34%) |  | |
Hemoglobulin (gm/dl) | ≥ 13.5 | 8(19%) | 61(59%) | 0.000* |
< 13.5 | 35(81%) | 43(41%) |  | |
Lymphocyte count (103/μl) | ≥1.85 | 16(37%) | 27(26%) | 0.173 |
< 1.85 | 27(63%) | 77(74%) |  | |
Monocyte count (102/μl) | ≥0.56 | 21(49%) | 43(41%) | 0.405 |
< 0.56 | 22(51%) | 61(59%) |  | |
Platelet count (103/μl) | ≥239 | 34(79%) | 44(42%) | 0.000* |
< 239 | 9(21%) | 60(58%) |  | |
Neutrophil count (103/μl) | ≥7.5 | 17(40%) | 28(17%) | 0.004* |
< 7.5 | 26(60%) | 86(83%) |  | |
LMR | ≥1.9 | 30(70%) | 80(77%) | 0.363 |
< 1.9 | 13(30%) | 24(23%) |  | |
PLR | ≥157 | 28(65%) | 49(47%) | 0.047* |
< 157 | 15(35%) | 55(53%) |  | |
NLR | ≥5.1 | 19(44%) | 28(27%) | 0.041* |
< 5.1 | 24(56%) | 76(63%) |  | |
SIRI | ≥553.7 | 10(23%) | 7(7%) | 0.004* |
< 553.7 | 33(77%) | 97(93%) |  | |
SII | ≥1820 | 16(37%) | 7(7%) | 0.000* |
< 1820 | 27(63%) | 97(93%) |  |